Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 10;139(10):1429-1430.
doi: 10.1182/blood.2021014505.

Danger ahead: COVID-19 infections after vaccination

Lee M Greenberger  1 , Gwen L Nichols  1
Affiliations
Editorial

Danger ahead: COVID-19 infections after vaccination

Lee M Greenberger et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

None
Progression of SARS-CoV-2 vaccination investigation in patients with hematologic malignancies compared with control-matched population. Moab, monoclonal antibody. The figure has been adapted from Figure 2 in the article by Mittelman et al that begins on page 1439.
See this image and copyright information in PMC

Comment on

References

    1. Mittelman M, Magen O, Barda N, et al. . Effectiveness of the BNT162b2mRNA COVID-19 vaccine in hematological patients in a nationwide mass vaccination setting. Blood. 2022;139(10):1439-1451. - PMC - PubMed
    1. Pagano L, Salmanton-García J, Marchesi F, et al. . COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA. Blood. 2022;139(10):1588-1592. - PMC - PubMed
    1. Ribas A, Dhodapkar MV, Campbell KM, et al. . How to provide a needed protection from COVID-19 to patients with hematologic malignancies. Blood Cancer Discov. 2021; 2(6):562-567. - PMC - PubMed
    1. Vijenthira A, Gong IY, Fox TA, et al. . Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881-2892. - PMC - PubMed
    1. Chung DJ, Shah GL, Devin SM, et al. . Disease and therapy specific impact on humoral immune response to COVID-19 vaccination in hematologic malignancies. Blood Cancer Discov. 2021;2(6):568-576. - PMC - PubMed